相关实验视频
Updated: Jan 14, 2026

06:07
Measuring Mitochondrial Function of Naïve and Effector CD8 T Cells
Published on: March 28, 2025
987
通过转录和代谢重编程,PARP抑制产生增强的CD8+中央记忆T细胞
Wael Traboulsi1, Pankaj Gaur1, Subhadip Kundu1
1Center for Advanced Immunotherapy Research & The Loop Immuno-Oncology Research Lab, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC, USA.
Nature immunology
|January 12, 2026
概括
聚基聚合酶 (PARP) 抑制增强CD8+T细胞,增强抗瘤免疫力. 这种重编程产生了优异的记忆T细胞,具有更好的回忆能力,用于更有效的癌症疗法.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 与效能记忆细胞相比,CD8+中央记忆T (TCM) 细胞提供了强大的抗瘤免疫力.
- 了解增强TCM细胞功能的机制对于改善癌症免疫疗法至关重要.
研究的目的:
- 为了研究聚ADP-ribose) 聚合酶 (PARP) 抑制对CD8+T细胞记忆的影响.
- 阐明涉及PARP抑制剂介导的T细胞重编程的分子途径.
主要方法:
- 在临床前小鼠模型和患者样本中使用了PARP抑制剂.
- 分析了T细胞种群,代谢适应性,基因表达和细胞周期状态.
- 评估免疫介导的抗瘤反应和采用细胞治疗的疗效.
主要成果:
- 抑制PARP激活了SIRT-1-FOXO1通路,诱导了CD8+ T细胞的代谢和转录转移.
- 重编程的CD8+T细胞表现出抑制细胞周期,增强脂肪酸氧化和优异的记忆回忆.
- 在小鼠中,PARP抑制剂治疗增加了瘤中的"高级TCM"细胞,改善了抗瘤免疫力和采用细胞治疗结果.
- 在接受PARP抑制剂治疗的癌症患者中观察到CD8+T细胞的频率增加和记忆标记表达.
结论:
- PARP 抑制直接将 CD8+ T 细胞重新编程成治疗上优异的记忆细胞.
- 重编程的T细胞增强的代谢适应性和回忆能力有助于改善抗瘤反应.
- PARP 抑制剂代表了增强基于 T 细胞的癌症免疫疗法的有希望的策略.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Somatic to iPS Cell Reprogramming
2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
T Cell Activation and Clonal Selection
14.7K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.7K
Negative Regulator Molecules
38.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.2K
Inhibition of Cdk Activity
5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K

